Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pneumocystis carinii growth kinetics in culture systems and in hosts: involvement of each life cycle parasite stage.

Literature DB >> 10519275

Pneumocystis carinii growth kinetics in culture systems and in hosts: involvement of each life cycle parasite stage.

L Dujardin, A Martinez, T Duriez, I Ricard, E Dei-Cas.

Abstract

Entities: Species

Mesh：

Year: 1999 PMID： 10519275

Source DB: PubMed Journal: J Eukaryot Microbiol ISSN： 1066-5234 Impact factor: 3.346

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

1. Pneumocystis pneumonia in an alcoholic patient with prolonged mechanical ventilation.

Authors: D Riebold; A Hennig; M Loebermann; W Schareck; E C Reisinger
Journal: Eur J Clin Microbiol Infect Dis Date: 2005-04 Impact factor: 3.267

2. In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats.

Authors: P Aviles; E M Aliouat; A Martinez; E Dei-Cas; E Herreros; L Dujardin; D Gargallo-Viola
Journal: Antimicrob Agents Chemother Date: 2000-05 Impact factor: 5.191

3. Pneumocystis carinii f. sp. hominis is not infectious for SCID mice.

Authors: Isabelle Durand-Joly; El Moukhtar Aliouat; Céline Recourt; Karine Guyot; Nadine François; Michèle Wauquier; Daniel Camus; Eduardo Dei-Cas
Journal: J Clin Microbiol Date: 2002-05 Impact factor: 5.948

4. In vitro and in vivo activity of iclaprim, a diaminopyrimidine compound and potential therapeutic alternative against Pneumocystis pneumonia.

Authors: E M Aliouat; E Dei-Cas; N Gantois; M Pottier; C Pinçon; S Hawser; A Lier; D B Huang
Journal: Eur J Clin Microbiol Infect Dis Date: 2018-01-12 Impact factor: 3.267

Pneumocystis carinii growth kinetics in culture systems and in hosts: involvement of each life cycle parasite stage.

1. Pneumocystis pneumonia in an alcoholic patient with prolonged mechanical ventilation.

2. In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats.

3. Pneumocystis carinii f. sp. hominis is not infectious for SCID mice.

4. In vitro and in vivo activity of iclaprim, a diaminopyrimidine compound and potential therapeutic alternative against Pneumocystis pneumonia.

Review 5. A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Review 6. Cryptococcus neoformans: Sex, morphogenesis, and virulence.

7. Ploidy of cell-sorted trophic and cystic forms of Pneumocystis carinii.

8. Complexity of the MSG gene family of Pneumocystis carinii.

9. SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs.

Review 10. The Persistent Challenge of Pneumocystis Growth Outside the Mammalian Lung: Past and Future Approaches.